CHOP方案治疗非何杰金氏恶性淋巴瘤疗效观察

来源 :中国实用医药 | 被引量 : 0次 | 上传用户:ary015
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的观察CHOP方案用于非何杰金氏恶性淋巴瘤临床治疗的效果及毒副作用。方法 82例非何杰金氏恶性淋巴瘤患者以CHOP方案施治,其中,初次治疗者42例为初治组,重复治疗者40例为复治组,比较两组疗效及毒副作用。结果初治组完全缓解(CR)、部分缓解(PR)、总有效率(RR)均与复治组比较,差异无统计学意义(P>0.05)。初治组的白细胞下降、血小板减少、脱发、指趾麻木皆显著低于复治组,差异有统计学意义(P<0.05)。结论采用CHOP方案治疗非何杰金氏恶性淋巴瘤患者,可使初次治疗、重复治疗者得到相似的疗效,但复治者的部分毒副作用比初治者严重,需得到重视。 Objective To observe the effect and side effects of CHOP regimen in the treatment of non-Hodgkin’s lymphoma. Methods Eighty - two non - Hodgkin ’s lymphoma patients were treated with CHOP regimen. Among them, 42 cases of initial treatment were treated with initial treatment and 40 cases with repeated treatment were treated with CHOP. The curative effect and side effect were compared between the two groups. Results The complete remission (CR), partial remission (PR) and total effective rate (RR) in the initial treatment group were significantly different from those in the retreatment group (P> 0.05). The initial treatment group leukopenia, thrombocytopenia, hair loss, toe numbness were significantly lower than the retreatment group, the difference was statistically significant (P <0.05). Conclusions The CHOP regimen is effective in the treatment of non-Hodgkin’s lymphoma patients with initial treatment and repeated treatment. However, some of the toxic and side effects of retreatment are more serious than those of the primary treatment and need attention.
其他文献
癌症是严重影响居民健康的危险因素,给患者家庭和社会带来沉重负担.癌症已经成为人类死亡的重要因素.晚期癌症患者及其家属都存在不同程度的焦虑、恐惧、痛苦及悲伤等不良情
在电动汽车示范应用和推广过程中,其续驶里程和能量消耗率一直是政府部门和消费者关注的焦点之一.本文报道了国家标准中对于电动汽车续驶里程和能量消耗率的计算与测试方法,
本文分析了教育装备产品溯源体系建设的可行性,并对科学构建提出建议。 This paper analyzes the feasibility of building traceability systems for educational equipmen
目的 研究探讨“合作教学模式”结合临床案例教学法在神经内科护理教学中的应用效果.方法 2017年9月~2018年8月,按照随机数字表法将入组患者及实习护生进行分组,包括对照组(接